Do analysts rate NVNI or SHPH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nvni Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is NVNI or SHPH more profitable?

Nvni Group's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Nvni Group N/A N/A N/A Shuttle Pharmaceuticals N/A -408.34% -138.15%

Do analysts recommend SHPH or CXAI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 CXApp 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate SHPH or ANY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Sphere 3D 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend SEAC or SHPH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SeaChange International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, SEAC or SHPH?

SeaChange International has higher revenue and earnings than Shuttle Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SeaChange International $32.76M 0.28 -$11.40M N/A N/A Shuttle Pharmaceuticals N/A N/A -$11.72M -$47.70 N/A

Is SEAC or SHPH more profitable?

SeaChange International's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets SeaChange International N/A N/A N/A Shuttle Pharmaceuticals N/A -408.34% -138.15%

Do analysts recommend DTSS or SHPH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Datasea 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Shuttle Pharmaceuticals (SHPH) Competitors

$4.36 -0.02 (-0.46%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$4.30 -0.06 (-1.47%)

As of 08/7/2026 07:56 PM Eastern

Compare

SHPH vs. NVNI, CXAI, ANY, SEAC, and DTSS

Should you buy Shuttle Pharmaceuticals stock or one of its competitors? MarketBeat compares Shuttle Pharmaceuticals with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Shuttle Pharmaceuticals include Nvni Group (NVNI), CXApp (CXAI), Sphere 3D (ANY), SeaChange International (SEAC), and Datasea (DTSS). These companies are all part of the "application software" industry.

How does Shuttle Pharmaceuticals compare to Nvni Group?

Nvni Group (NASDAQ:NVNI) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, media sentiment, institutional ownership and analyst recommendations.

Shuttle Pharmaceuticals has lower revenue, but higher earnings than Nvni Group. Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than Nvni Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nvni Group	$196.74M	0.05	-$20.22M	$0.40	2.63
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$47.70	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nvni Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Nvni Group's average media sentiment score of 0.00 equaled Shuttle Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Nvni Group	Neutral
Shuttle Pharmaceuticals	Neutral

Nvni Group's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nvni Group	N/A	N/A	N/A
Shuttle Pharmaceuticals	N/A	-408.34%	-138.15%

0.5% of Nvni Group shares are owned by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. 20.0% of Nvni Group shares are owned by insiders. Comparatively, 1.3% of Shuttle Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Nvni Group has a beta of -0.07, suggesting that its share price is 107% less volatile than the broader market. Comparatively, Shuttle Pharmaceuticals has a beta of 0.21, suggesting that its share price is 79% less volatile than the broader market.

Summary

Nvni Group beats Shuttle Pharmaceuticals on 6 of the 9 factors compared between the two stocks.

How does Shuttle Pharmaceuticals compare to CXApp?

Shuttle Pharmaceuticals (NASDAQ:SHPH) and CXApp (NASDAQ:CXAI) are both small-cap technology companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

In the previous week, CXApp had 1 more articles in the media than Shuttle Pharmaceuticals. MarketBeat recorded 1 mentions for CXApp and 0 mentions for Shuttle Pharmaceuticals. Shuttle Pharmaceuticals' average media sentiment score of 0.00 equaled CXApp'saverage media sentiment score.

Company	Overall Sentiment
Shuttle Pharmaceuticals	Neutral
CXApp	Neutral

Shuttle Pharmaceuticals has a net margin of 0.00% compared to CXApp's net margin of -368.07%. CXApp's return on equity of -106.67% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shuttle Pharmaceuticals	N/A	-408.34%	-138.15%
CXApp	-368.07%	-106.67%	-51.35%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
CXApp	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Shuttle Pharmaceuticals has a beta of 0.21, indicating that its stock price is 79% less volatile than the broader market. Comparatively, CXApp has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market.

4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. Comparatively, 14.4% of CXApp shares are held by institutional investors. 1.3% of Shuttle Pharmaceuticals shares are held by company insiders. Comparatively, 3.3% of CXApp shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Shuttle Pharmaceuticals has higher earnings, but lower revenue than CXApp. CXApp is trading at a lower price-to-earnings ratio than Shuttle Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$47.70	N/A
CXApp	$4.31M	2.60	-$13.47M	-$0.58	N/A

Summary

CXApp beats Shuttle Pharmaceuticals on 8 of the 11 factors compared between the two stocks.

How does Shuttle Pharmaceuticals compare to Sphere 3D?

Shuttle Pharmaceuticals (NASDAQ:SHPH) and Sphere 3D (NASDAQ:ANY) are both small-cap technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation and media sentiment.

Shuttle Pharmaceuticals has higher earnings, but lower revenue than Sphere 3D. Sphere 3D is trading at a lower price-to-earnings ratio than Shuttle Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$47.70	N/A
Sphere 3D	$11.18M	1.62	-$21.48M	-$3.48	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Sphere 3D	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. Comparatively, 17.3% of Sphere 3D shares are held by institutional investors. 1.3% of Shuttle Pharmaceuticals shares are held by insiders. Comparatively, 6.4% of Sphere 3D shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Shuttle Pharmaceuticals' average media sentiment score of 0.00 equaled Sphere 3D'saverage media sentiment score.

Company	Overall Sentiment
Shuttle Pharmaceuticals	Neutral
Sphere 3D	Neutral

Shuttle Pharmaceuticals has a beta of 0.21, suggesting that its stock price is 79% less volatile than the broader market. Comparatively, Sphere 3D has a beta of 3.47, suggesting that its stock price is 247% more volatile than the broader market.

Shuttle Pharmaceuticals has a net margin of 0.00% compared to Sphere 3D's net margin of -163.45%. Sphere 3D's return on equity of -78.14% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shuttle Pharmaceuticals	N/A	-408.34%	-138.15%
Sphere 3D	-163.45%	-78.14%	-73.36%

Summary

Sphere 3D beats Shuttle Pharmaceuticals on 7 of the 10 factors compared between the two stocks.

How does Shuttle Pharmaceuticals compare to SeaChange International?

SeaChange International (NASDAQ:SEAC) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap technology companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

In the previous week, SeaChange International's average media sentiment score of 0.00 equaled Shuttle Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
SeaChange International	Neutral
Shuttle Pharmaceuticals	Neutral

SeaChange International has higher revenue and earnings than Shuttle Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaChange International	$32.76M	0.28	-$11.40M	N/A	N/A
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$47.70	N/A

SeaChange International has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market. Comparatively, Shuttle Pharmaceuticals has a beta of 0.21, indicating that its stock price is 79% less volatile than the broader market.

SeaChange International's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaChange International	N/A	N/A	N/A
Shuttle Pharmaceuticals	N/A	-408.34%	-138.15%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaChange International	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. 3.9% of SeaChange International shares are owned by company insiders. Comparatively, 1.3% of Shuttle Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

SeaChange International beats Shuttle Pharmaceuticals on 6 of the 9 factors compared between the two stocks.

How does Shuttle Pharmaceuticals compare to Datasea?

Datasea (NASDAQ:DTSS) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap technology companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability.

Datasea has a beta of 0.79, meaning that its share price is 21% less volatile than the broader market. Comparatively, Shuttle Pharmaceuticals has a beta of 0.21, meaning that its share price is 79% less volatile than the broader market.

Shuttle Pharmaceuticals has a net margin of 0.00% compared to Datasea's net margin of -4.80%. Datasea's return on equity of -88.98% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Datasea	-4.80%	-88.98%	-37.33%
Shuttle Pharmaceuticals	N/A	-408.34%	-138.15%

Datasea has higher revenue and earnings than Shuttle Pharmaceuticals. Datasea is trading at a lower price-to-earnings ratio than Shuttle Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Datasea	$71.62M	0.11	-$5.09M	-$0.32	N/A
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$47.70	N/A

In the previous week, Datasea had 1 more articles in the media than Shuttle Pharmaceuticals. MarketBeat recorded 1 mentions for Datasea and 0 mentions for Shuttle Pharmaceuticals. Datasea's average media sentiment score of 0.92 beat Shuttle Pharmaceuticals' score of 0.00 indicating that Datasea is being referred to more favorably in the media.

Company	Overall Sentiment
Datasea	Positive
Shuttle Pharmaceuticals	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Datasea	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

82.1% of Datasea shares are held by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. 50.7% of Datasea shares are held by insiders. Comparatively, 1.3% of Shuttle Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Datasea beats Shuttle Pharmaceuticals on 10 of the 12 factors compared between the two stocks.

Get Shuttle Pharmaceuticals News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SHPH vs. The Competition

Export

Metric	Shuttle Pharmaceuticals	Software Industry	Technology Sector	NASDAQ Exchange
Market Cap	$2.78M	$15.75B	$30.05B	$13.00B
Dividend Yield	N/A	3.43%	2.73%	10.20%
P/E Ratio	-0.09	126.92	75.93	25.19
Price / Sales	N/A	1,301.96	601.69	80.06
Price / Cash	N/A	46.46	51.50	50.72
Price / Book	0.39	6.72	9.28	6.22
Net Income	-$11.72M	$436.21M	$661.55M	$342.66M
7 Day Performance	14.74%	3.79%	4.84%	4.41%
1 Month Performance	32.93%	1.32%	-0.13%	-1.10%
1 Year Performance	-87.25%	9.06%	203.19%	23.99%

Shuttle Pharmaceuticals Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SHPH Shuttle Pharmaceuticals	0.6413 of 5 stars	$4.36 -0.5%	N/A	-87.3%	$2.78M	N/A	N/A	5	Analyst Upgrade Gap Up
NVNI Nvni Group	1.0719 of 5 stars	$1.09 -8.4%	N/A	-83.3%	$10.93M	$35.23M	2.73	N/A
CXAI CXApp	0.6961 of 5 stars	$0.14 -1.0%	N/A	-82.6%	$9.93M	$4.58M	N/A	2	News Coverage Upcoming Earnings Gap Up
ANY Sphere 3D	0.8412 of 5 stars	$2.28 +0.9%	N/A	-57.3%	$9.68M	$10.28M	N/A	20
SEAC SeaChange International	N/A	$3.30 +0.6%	N/A	-34.7%	$9.27M	$32.76M	N/A	100

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SHPH) was last updated on 8/9/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Shuttle Pharmaceuticals (SHPH) Competitors

SHPH vs. NVNI, CXAI, ANY, SEAC, and DTSS

How does Shuttle Pharmaceuticals compare to Nvni Group?

Summary

How does Shuttle Pharmaceuticals compare to CXApp?

Summary

How does Shuttle Pharmaceuticals compare to Sphere 3D?

Summary

How does Shuttle Pharmaceuticals compare to SeaChange International?

Summary

How does Shuttle Pharmaceuticals compare to Datasea?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHPH vs. The Competition

Shuttle Pharmaceuticals Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Shuttle Pharmaceuticals (SHPH) Competitors

SHPH vs. NVNI, CXAI, ANY, SEAC, and DTSS

How does Shuttle Pharmaceuticals compare to Nvni Group?

Which has preferable valuation & earnings, NVNI or SHPH?

Do analysts rate NVNI or SHPH?

Does the media refer more to NVNI or SHPH?

Is NVNI or SHPH more profitable?

Do insiders and institutionals believe in NVNI or SHPH?

Which has more volatility and risk, NVNI or SHPH?

Summary

How does Shuttle Pharmaceuticals compare to CXApp?

Does the media prefer SHPH or CXAI?

Is SHPH or CXAI more profitable?

Do analysts recommend SHPH or CXAI?

Which has more risk & volatility, SHPH or CXAI?

Do institutionals and insiders believe in SHPH or CXAI?

Which has preferable valuation & earnings, SHPH or CXAI?

Summary

How does Shuttle Pharmaceuticals compare to Sphere 3D?

Which has better earnings and valuation, SHPH or ANY?

Do analysts rate SHPH or ANY?

Do insiders and institutionals believe in SHPH or ANY?

Does the media prefer SHPH or ANY?

Which has more risk and volatility, SHPH or ANY?

Is SHPH or ANY more profitable?

Summary

How does Shuttle Pharmaceuticals compare to SeaChange International?

Does the media refer more to SEAC or SHPH?

Which has better valuation & earnings, SEAC or SHPH?

Which has more volatility & risk, SEAC or SHPH?

Is SEAC or SHPH more profitable?

Do analysts recommend SEAC or SHPH?

Do institutionals and insiders have more ownership in SEAC or SHPH?

Summary

How does Shuttle Pharmaceuticals compare to Datasea?

Which has more volatility & risk, DTSS or SHPH?

Is DTSS or SHPH more profitable?

Which has preferable earnings & valuation, DTSS or SHPH?

Does the media favor DTSS or SHPH?

Do analysts recommend DTSS or SHPH?

Do insiders and institutionals believe in DTSS or SHPH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHPH vs. The Competition

Shuttle Pharmaceuticals Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools